The present invention is based on the discovery that amyotrophic lateral sclerosis (ALS), Parkinson disease and Alzheimer disease are due to lack of a disorder-specific neurotrophic hormone. Diagnosis is accomplished by assaying hormones specific for a particular neuronal network or system: the motor ...
Diagnosis of Alzheimer disease 专利名称：Diagnosis of Alzheimer disease 发明人：Stanley H. Appel 申请号：US06/769861 申请日：19850823 公开号：US04701407A 公开日：19871020 专利内容由知识产权出版社提供 摘要：The present invention is based on the discovery that amyotrophic lateral sclerosis (ALS), ...
申请(专利权)人: BAYLOR COLLEGE OF MEDICINE 发明人: STANLEY H. APPEL 被引量: 19 摘要: The present invention is based on the discovery that amyotrophic lateral sclerosis (ALS), Parkinson disease and Alzheimer disease are due to lack of a disorder-specific neurotrophic hormone. Diagnosis is...
Motor Neuron Disease Population-BASED Patient Registry Outcome Measure DiagnosisPatient-specific (endogenous) and population-specific (exogenous) risk factor analysis is identifying novel physical and chemical exposures which might be time-linked to the development of amyotrophic lateral sclerosis (ALS) and...
With the Alzheimer's Disease Neuroimaging Initiative (ADNI) as a model, international scientists with focus on the application of MRI to ALS met at the ... MR Turner,J Grosskreutz,J Kassubek,... - 《Lancet Neurology》 被引量: 265发表: 2011年 Postictal psychiatric events during prolonged ...
Confirming a diagnosis of amyotrophic lateral sclerosis (ALS) is typically a complex process that involves testing for signs indicative of the progressive neurodegenerative disease, and ruling out other potential disorders that could cause similar symptoms....
Genetic factors may be involved even without a family history of ALS and may be underestimated. The disease course and progression are highly variable. Symptom severity and rate of progression are determined by the ALS Functional Scale (ALSFRS-R). Beyond clinical symptoms and the patient's ...
Informing patients and their families about a diagnosis such as amyotrophic lateral sclerosis (ALS) is a daunting task for any physician. The way the diagnosis is communicated will have a major impact on the physician-patient relationship and the attitude of the patient toward the disease and towa...
AD = Alzheimer’s disease; GOA = general older adult. Full size image Prescription rates In the first post-diagnosis 6-month period, 37.5% of patients in the AD cohort were prescribed at least one AChE inhibitor (Figure 4). Unsurprisingly, due to the way the cohort was defined,...
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disease with largely unknown etiology. This study compares racial differences in clinical characteristics of ALS patients enrolled in the National ALS Registry (Registry).Data from ALS patients who completed the Registry's online clinical survey...